290650.KQ
L&C Bio Co., Ltd
KOE · Healthcare · Medical - Specialties · KR
KRW 48,600.00
−10.00%Margins
Gross margin
57.2%
EBITDA margin
14.7%
EBIT margin
16.7%
Net margin
-128.6%
FCF margin
-3.4%
-46.0%
Return on equity
-31.3%
Return on assets
5.0%
Return on invested capital
0.25x
Asset turnover
KRW 26.1B
Cash from operations
KRW 1.6K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026